BiotechTube
Home/Venturis Therapeutics/Calvin A. Wallen III
CA

Calvin A. Wallen III

President, Chairman of the Board

Venturis Therapeutics

Therapeutic Areas

CardiovascularMetabolic DisordersNeurologyUrologyMusculoskeletal

Venturis Therapeutics Pipeline

DrugIndicationPhase
FGF-based TherapeuticDiabetic Wounds / Severe Ischemic Heart Disease / Peripheral Artery DiseasePhase 2

Leadership Team at Venturis Therapeutics

RS
Robert Schleizer
Chief Financial Officer (CFO)
DG
David G. Armstrong, DPM, MD, PhD
Affiliated Clinical Advisor (Diabetic Foot)
View full Venturis Therapeutics profile